Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER METABOLISM

New tricks for an old drug

Nature Chemical Biology volume 14, pages 990–991 (2018)Cite this article

Subjects

The prodrug dimethyloxalylglycine (DMOG) is a well-known tool compound used to study hypoxia. New findings reveal that DMOG also inhibits glutamine metabolism and can be exploited to selectively kill some cancer cells, highlighting important caveats when using DMOG for hypoxia studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: DMOG metabolism and inhibitory activities.

References

  1. Semenza, G. L. Genes Dev. 14, 1983–1991 (2000).

    CAS  PubMed  Google Scholar 

  2. Cunliffe, C. J., Franklin, T. J., Hales, N. J. & Hill, G. B. J. Med. Chem. 35, 2652–2658 (1992).

    Article  CAS  Google Scholar 

  3. Majmundar, A. J., Wong, W. J. & Simon, M. C. Mol. Cell 40, 294–309 (2010).

    Article  CAS  Google Scholar 

  4. Pavlova, N. N. & Thompson, C. B. Cell Metab. 23, 27–47 (2016).

    Article  CAS  Google Scholar 

  5. Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J. & Schofield, C. J. Annu. Rev. Biochem. 87, 585–620 (2018).

    Article  CAS  Google Scholar 

  6. Louise Fets, P. C. D. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-018-0136-y (2018).

  7. Lin, R. Y., Vera, J. C., Chaganti, R. S. & Golde, D. W. J. Biol. Chem. 273, 28959–28965 (1998).

    Article  CAS  Google Scholar 

  8. Maxwell, P. H. & Eckardt, K. U. Nat. Rev. Nephrol. 12, 157–168 (2016).

    Article  CAS  Google Scholar 

  9. Leung, I. K. et al. J. Med. Chem. 56, 547–555 (2013).

    Article  CAS  Google Scholar 

  10. Rendina, A. R. et al. Biochemistry 52, 4563–4577 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA

    Barbara S. Nelson, Daniel M. Kremer & Costas A. Lyssiotis

  2. Rogel Cancer Center and Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA

    Costas A. Lyssiotis

Authors
  1. Barbara S. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel M. Kremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Costas A. Lyssiotis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Costas A. Lyssiotis.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nelson, B.S., Kremer, D.M. & Lyssiotis, C.A. New tricks for an old drug. Nat Chem Biol 14, 990–991 (2018). https://doi.org/10.1038/s41589-018-0137-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-018-0137-x

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer